Autopsy report · NCT04216303

Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus

“PI decided to stop the study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Sponsor

Methodist Health System

Sponsor type

University, hospital or other

Conditions

Diabetes; Liver Transplant; Complications; Kidney Transplant Failure

Interventions

hemoglobin A1c

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Affective Processing in Depression and Epilepsy
  “PI wanted to discontinue study.” (83% match in meaning)
• Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
  “Study PI left the institution and study was stopped at that time.” (83% match in meaning)
• Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
  “Study closed with no subjects accrued. PI decided to stop study.” (83% match in meaning)
• Comparison of Quadratus Lumborum Block Types
  “PI left the institution. Decision made to close the study.” (83% match in meaning)
• Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples
  “no PI to continue the study” (83% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.